Editorial [Hot Topic:Anti-Cancer-Drugs (Executive Editor: E. Bergmann-Leitner)]

E-ISSN： 1873-4286|13|33|3357-3357

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.33, 2007-11, pp. : 3357-3357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Novel Anti-Cancer Drugs and Therapeutic Approaches (Executive Editor: E. Bergmann-Leitner)]

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 259-260

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1048-1048

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial:Hot Topic: [Anti-Cancer Drugs(Executive Editor: Elke Bergmann-Leitner)]

Current Pharmaceutical Design, Vol. 15, Iss. 7, 2009-03 ,pp. : 730-731

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Anti-Cancer Drugs (Executive Editor: Elke S. Bergmann-Leitner)]

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1077-1078

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Anti-Cancer Drugs (Executive Editor : Elke Bergmann-Leitner)]

Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite